首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1781301

全球髂动脉支架市场

Iliac Stents

出版日期: 2025年08月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 377 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球髂动脉支架市场规模将达 11 亿美元

全球髂动脉支架市场规模预计在2024年达到9.167亿美元，预计在2024-2030年的分析期间内将以3.4%的复合年增长率增长，到2030年将达到11亿美元。自动扩张型支架支架是本报告分析的细分市场之一，预计其复合年增长率为2.6%，到分析期结束时规模将达到5.806亿美元。球囊扩张型支架在分析期间的复合年增长率预计为4.5%。

美国市场规模估计为 2.497 亿美元，中国市场预计复合年增长率为 6.2%

预计到2024年，美国髂动脉支架市场规模将达到2.497亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到2.208亿美元，2024年至2030年的复合年增长率为6.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.4%和2.6%。在欧洲，预计德国市场的复合年增长率为1.9%。

髂动脉支架：为何其对于治疗周边动脉疾病和复杂血管疾病至关重要

全球髂动脉支架市场－主要趋势与驱动因素摘要

全球髂动脉支架市场正在经历显着增长，这得益于周边动脉疾病(PAD) 盛行率的上升、对微创血管介入治疗的需求不断增长以及支架技术的持续进步。髂动脉支架用于治疗髂动脉的阻塞或狭窄（狭窄），髂动脉为骨盆和下肢供血。这种疾病通常由动脉粥状硬化引起，如果不及时治疗，会导致严重的肢体缺血。老年患者以及患有糖尿病、高血压和高血脂症等併发症的患者对髂动脉支架的需求尤其强烈，因为他们更容易出现血管併发症。

近年来，开放性手术转向血管内治疗 (EVT)，髂动脉置入术因其发病率较低、住院时间较短、恢復速度较快而成为黄金标准。血管诊断可及性的提高、医疗保险覆盖范围的扩大以及全球週边动脉疾病 (PAD)筛检计画的增加也推动了市场的成长。同时，临床医生对髂动脉疾病早期发现和积极治疗的认识不断提高，尤其是在高风险族群中。这些动态正为已开发市场及新兴市场带来强劲的支架置入术及相关器材需求。

哪些创新正在改善髂骨支架的设计和结果？

支架设计和输送系统的技术进步是市场扩张的主要驱动力。製造商不断创新，以提高支架的灵活性、径向强度和长期通畅性，特别是在髂骨分叉等复杂的解剖区域。自动扩张型支架通常由镍钛诺（一种镍钛合金）製成，由于其顺应性和抗外部压缩性，在弯曲或移动的动脉中是首选。另一方面，球囊扩张型支架允许精确放置并提供更大的径向力，使其适用于高度钙化或局部病变。结合了两种支架优点的混合支架也越来越受欢迎。

药物释放型支架 (DES) 已成为一项突破性技术，可释放紫杉醇和Sirolimus等抗增殖药物，从而降低血管再阻塞率。虽然 DES 通常用于冠状动脉，但良好的临床结果已使其广泛应用于包括髂动脉在内的周边动脉。此外，正在开发生物可吸收支架和无聚合物涂层，以尽量减少长期併发症，例如晚期支架血栓症形成。输送系统的改进，包括细导管和亲水涂层，有助于在复杂病灶中导航并缩短手术时间。这些技术进步使髂动脉置入术更安全、更有效率、更耐用，同时扩大了病患群体。

髂骨支架的需求在哪里增加？

北美和西欧凭藉其先进的医疗基础设施、较高的周边动脉疾病 (PAD) 盛行率以及早期采用新型血管技术，继续在髂动脉支架市场占据主导地位。尤其是美国，其凭藉其完善的临床指南支持血管内治疗，且週边动脉疾病 (PAD) 治疗的报销范围广泛，成为领先的市场。德国、法国和英国等欧洲国家也因其人口老化和积极的血管筛检措施而显示出强劲的需求。

亚太地区已成为一个高成长市场，其中以中国、印度和日本为主导。公共卫生意识的增强、介入性心臟病学和放射学服务可及性的提高以及心血管危险因素负担的增加等因素推动了手术量的增加。此外，这些地区的政府正在投资发展三级医疗机构和农村推广计划，以提高週边动脉疾病（PAD）的诊断和干预的可及性。受医疗旅游、保险渗透率和医疗保健基础设施改善的推动，拉丁美洲以及中东和非洲部分地区也在逐步采用周边动脉疾病 (PAD)。在所有地区，医生培训的加强以及医疗设备製造商和医院之间的策略合作伙伴关係的建立正在加速髂动脉留置技术的推广。

髂动脉支架市场的成长受到多种因素的推动…

髂动脉支架市场的成长受到多种因素的驱动，这些因素与疾病流行程度、技术进步以及终端应用的不断扩展有关。其中一个关键驱动因素是全球周边动脉疾病发病率的上升，而人口老化以及吸烟、超音波和久坐不动等生活方式相关的风险因素是导致这一现象的根源。随着週边动脉疾病 (PAD) 的日益普遍，对髂动脉支架等有效重组手术的需求持续成长。此外，双层超音波、CT血管摄影和磁振造影血管摄影等诊断影像技术的进步，有助于早期准确地识别髂动脉狭窄。

技术创新仍然是市场扩张的关键。新型支架平台的开发，使其能够提高输送能力、减少血管再阻塞并延长耐用性，从而吸引医生的偏好并改善临床疗效。随着低调、微创支架系统的兴起，终端应用也正在从传统的血管中心扩展到门诊和门诊手术中心。此外，有利的监管核准、不断增加的临床试验证据以及支付方对血管内治疗的支持力度不断加大，正在推动支架系统更广泛的应用。

最后，全球医疗保健趋势，例如转向基于价值的医疗模式、患者意识的提升以及人工智慧与血管诊断的融合，正在重塑髂动脉疾病的治疗方式。这些趋势强化了髂动脉支架作为週边动脉疾病（PAD）第一线治疗手段的策略重要性，并确保了不同地区、医疗机构和患者群体对髂动脉支架的需求持续成长。

部分

类型（自动扩张型支架型、球囊扩张型支架型、覆膜支架型）；动脉病变（髂总动脉病变、重度钙化性动脉病变、完全闭塞性动脉病变）；最终用户（医院最终用户、门诊手术中心最终用户、其他最终用户）

受访公司范例

Abbott Laboratories
Alvimedica
B. Braun Melsungen AG
Becton, Dickinson and Company（BD）
Biotronik SE & Co. KG
Boston Scientific Corporation
CR Bard, Inc.
Cardinal Health, Inc.
Cook Medical LLC
Cordis Corporation
Endologix LLC
Getinge AB
iVascular
Jotec GmbH
LeMaitre Vascular, Inc.
Medtronic plc
MicroPort Scientific Corporation
OptiMed Medizinische Instrumente GmbH
Terumo Corporation
WL Gore & Associates, Inc.

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

The global market for Iliac Stents estimated at US$916.7 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Self-Expandable Stents Type, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$580.6 Million by the end of the analysis period. Growth in the Balloon-Expandable Stents Type segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$249.7 Million While China is Forecast to Grow at 6.2% CAGR

The Iliac Stents market in the U.S. is estimated at US$249.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$220.8 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Iliac Stents: Why Are They Pivotal in Managing Peripheral Artery Disease and Complex Vascular Conditions?

Global Iliac Stents Market - Key Trends & Drivers Summarized

The global iliac stents market is experiencing significant growth, fueled by the rising prevalence of peripheral artery disease (PAD), increased demand for minimally invasive vascular interventions, and ongoing advancements in stent technology. Iliac stents are deployed to treat occlusions or narrowing (stenosis) in the iliac arteries, which supply blood to the pelvis and lower limbs. This condition often stems from atherosclerosis and can lead to critical limb ischemia if left untreated. The demand for iliac stents is particularly strong in elderly populations and patients with comorbidities such as diabetes, hypertension, and hyperlipidemia-conditions that predispose individuals to vascular complications.

Recent years have seen a shift from open surgical repair to endovascular treatment (EVT), with iliac stenting becoming the gold standard due to its lower morbidity, shorter hospital stays, and quicker recovery. Market growth is also being supported by increasing access to vascular diagnostics, expanded health insurance coverage, and a rising number of PAD screening programs globally. In parallel, there is growing awareness among clinicians regarding early detection and aggressive treatment of iliac artery disease, especially in high-risk populations. These dynamics are contributing to a strong demand pipeline for stenting procedures and related devices in both developed and emerging healthcare markets.

What Technological Innovations Are Enhancing Iliac Stent Design and Outcomes?

Technological advancement in stent design and delivery systems is a key driver of market expansion. Manufacturers are continuously innovating to improve stent flexibility, radial strength, and long-term patency-especially in complex anatomical regions like the iliac bifurcation. Self-expanding stents, typically made of nitinol (a nickel-titanium alloy), are favored in tortuous or mobile arteries due to their conformability and resistance to external compression. Balloon-expandable stents, on the other hand, offer precision placement and higher radial force, making them suitable for heavily calcified or focal lesions. Hybrid stents that combine the benefits of both designs are also gaining traction.

Drug-eluting stents (DES) have emerged as a game-changer, releasing antiproliferative agents such as paclitaxel or sirolimus to reduce restenosis rates. While DES are more commonly used in coronary arteries, their application in peripheral settings-including the iliac arteries-is expanding due to favorable clinical outcomes. In addition, bioresorbable scaffolds and polymer-free coatings are under development to minimize long-term complications such as late stent thrombosis. Improved delivery systems, including low-profile catheters and hydrophilic coatings, are making it easier to navigate complex lesions and reduce procedure time. These innovations are making iliac stenting safer, more efficient, and more durable, while expanding eligibility to broader patient populations.

Where Is Market Demand for Iliac Stents Growing - And What’s Driving It?

North America and Western Europe continue to dominate the iliac stents market, owing to advanced healthcare infrastructure, high prevalence of PAD, and early adoption of novel vascular technologies. The U.S., in particular, is a key market due to robust clinical guidelines supporting endovascular interventions and extensive reimbursement coverage for PAD treatment. European countries such as Germany, France, and the UK also exhibit strong demand, driven by aging populations and proactive vascular screening initiatives.

The Asia-Pacific region is emerging as a high-growth market, with China, India, and Japan leading the charge. Factors such as growing public health awareness, expanding access to interventional cardiology and radiology services, and a rising burden of cardiovascular risk factors are driving increased procedural volumes. Furthermore, governments in these regions are investing in the development of tertiary healthcare facilities and rural outreach programs, enhancing access to PAD diagnosis and intervention. Latin America, the Middle East, and parts of Africa are also witnessing gradual uptake as medical tourism, insurance penetration, and healthcare infrastructure improve. Across all regions, increasing physician training and strategic partnerships between medical device manufacturers and hospitals are accelerating the diffusion of iliac stenting technologies.

The Growth in the Iliac Stents Market Is Driven by Several Factors…

The growth in the iliac stents market is driven by several factors related to disease prevalence, technological advancement, and end-use expansion. A primary driver is the rising global incidence of peripheral artery disease, fueled by aging demographics and lifestyle-related risk factors such as smoking, obesity, and sedentary behavior. As PAD becomes more common, the need for effective revascularization options like iliac stents continues to increase. In addition, improvements in diagnostic imaging-such as duplex ultrasonography, CT angiography, and MR angiography-are facilitating early and accurate identification of iliac artery stenosis.

Technological innovation remains a cornerstone of market expansion. The development of new stent platforms-offering enhanced deliverability, reduced restenosis, and longer durability-is attracting physician preference and improving clinical outcomes. End-use applications are also expanding beyond traditional vascular centers to include outpatient clinics and ambulatory surgical centers, enabled by the rise of low-profile, minimally invasive stent systems. Furthermore, favorable regulatory approvals, increasing clinical trial evidence, and growing payer support for endovascular procedures are driving broader adoption.

Lastly, global healthcare trends-such as the shift toward value-based care, increased patient awareness, and integration of artificial intelligence in vascular diagnostics-are reshaping how iliac artery disease is treated. These trends are reinforcing the strategic importance of iliac stents as a frontline therapy for PAD and ensuring sustained demand across regions, healthcare settings, and patient populations.

SCOPE OF STUDY:

The report analyzes the Iliac Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Self-Expandable Stents Type, Balloon-Expandable Stents Type, Covered Stents Type); Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Artery Lesions, Complete Obstructive Artery Lesions); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

Abbott Laboratories
Alvimedica
B. Braun Melsungen AG
Becton, Dickinson and Company (BD)
Biotronik SE & Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cardinal Health, Inc.
Cook Medical LLC
Cordis Corporation
Endologix LLC
Getinge AB
iVascular
Jotec GmbH
LeMaitre Vascular, Inc.
Medtronic plc
MicroPort Scientific Corporation
OptiMed Medizinische Instrumente GmbH
Terumo Corporation
W. L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Iliac Stents - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of Peripheral Arterial Disease Spurs Demand for Iliac Stents
- Aging Population and Vascular Comorbidities Expand Addressable Market for Endovascular Therapies
- Advancements in Stent Design and Coating Technologies Drive Product Innovation
- Increasing Preference for Minimally Invasive Interventions Propels Iliac Stent Procedure Volume
- Favorable Clinical Outcomes and Long-Term Patency Rates Strengthen Business Case for Iliac Stents
- Expansion of Outpatient Vascular Surgery Centers Enhances Accessibility and Adoption
- Technological Integration in Imaging and Navigation Systems Improves Placement Precision
- Growing Use of Drug-Eluting Stents in Iliac Artery Treatments Accelerates Market Growth
- Rising Awareness and Screening for Peripheral Vascular Disorders Throw Spotlight on Early Intervention
- Clinical Guidelines Endorsing Endovascular Iliac Stenting Drive Physician Adoption
- Product Innovation in Self-Expanding and Balloon-Expandable Stents Expands Therapeutic Options
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Iliac Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Iliac Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Self-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Self-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Self-Expandable Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Balloon-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Balloon-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Balloon-Expandable Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Covered Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Covered Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Covered Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Common Iliac Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Common Iliac Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Common Iliac Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Severe Calcified Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Severe Calcified Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Severe Calcified Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Complete Obstructive Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Complete Obstructive Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Complete Obstructive Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: USA 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: USA 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
- TABLE 41: Canada Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: Canada 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 44: Canada Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: Canada 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 47: Canada Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Canada 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 50: Japan Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Japan Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Japan 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 53: Japan Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Japan 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Japan 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 59: China Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: China Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: China 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: China Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: China 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 65: China Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: China 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 68: Europe Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Iliac Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: Europe 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: Europe 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: Europe 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Europe 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 80: France Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: France Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: France 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 83: France Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: France Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: France 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 86: France Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: France 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 89: Germany Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Germany Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: Germany 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: Germany 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 95: Germany Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Germany 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
- TABLE 98: Italy Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Italy Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Italy 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 101: Italy Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Italy 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 104: Italy Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: Italy 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 107: UK Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: UK Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: UK 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 110: UK Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: UK 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 113: UK Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: UK 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
- TABLE 116: Spain Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: Spain Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: Spain 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 119: Spain Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: Spain Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: Spain 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 122: Spain Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: Spain 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 125: Russia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Russia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: Russia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 128: Russia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Russia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: Russia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 131: Russia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Russia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Rest of Europe Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: Rest of Europe 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Rest of Europe Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: Rest of Europe 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: Rest of Europe 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 144: Asia-Pacific Historic Review for Iliac Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 145: Asia-Pacific 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Asia-Pacific Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 148: Asia-Pacific 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 151: Asia-Pacific 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 155: Australia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Australia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 157: Australia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 158: Australia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Australia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 160: Australia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 161: Australia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 163: Australia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
INDIA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 164: India Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: India Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 166: India 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 167: India Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: India Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 169: India 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 170: India Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: India Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 172: India 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 173: South Korea Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: South Korea Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 175: South Korea 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 176: South Korea Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: South Korea Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 178: South Korea 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 181: South Korea 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: Rest of Asia-Pacific Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Rest of Asia-Pacific Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
LATIN AMERICA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 191: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 192: Latin America Historic Review for Iliac Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 193: Latin America 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 194: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Latin America Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 196: Latin America 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 199: Latin America 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 202: Latin America 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 203: Argentina Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Argentina Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 205: Argentina 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 206: Argentina Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Argentina Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 208: Argentina 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 211: Argentina 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 212: Brazil Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Brazil Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 214: Brazil 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 215: Brazil Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: Brazil Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 217: Brazil 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 220: Brazil 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MEXICO
- TABLE 221: Mexico Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Mexico Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 223: Mexico 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 224: Mexico Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Mexico Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 226: Mexico 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 229: Mexico 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Rest of Latin America Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 232: Rest of Latin America 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Rest of Latin America Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 235: Rest of Latin America 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 238: Rest of Latin America 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MIDDLE EAST
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 239: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 240: Middle East Historic Review for Iliac Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 241: Middle East 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 242: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: Middle East Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 244: Middle East 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 247: Middle East 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 250: Middle East 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
IRAN
- TABLE 251: Iran Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Iran Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 253: Iran 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 254: Iran Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Iran Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 256: Iran 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 257: Iran Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 259: Iran 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 260: Israel Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Israel Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 262: Israel 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 263: Israel Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Israel Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 265: Israel 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 266: Israel Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 268: Israel 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Saudi Arabia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 271: Saudi Arabia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Saudi Arabia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 274: Saudi Arabia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 277: Saudi Arabia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 278: UAE Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: UAE Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 280: UAE 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 281: UAE Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: UAE Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 283: UAE 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 284: UAE Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 286: UAE 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: Rest of Middle East Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 289: Rest of Middle East 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: Rest of Middle East Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 292: Rest of Middle East 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 295: Rest of Middle East 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AFRICA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 296: Africa Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Africa Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 298: Africa 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 299: Africa Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Africa Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 301: Africa 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 302: Africa Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 304: Africa 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

02-2729-4219

+886-2-2729-4219

License/价格

全球髂动脉支架市场